Adeno-associated Virus Vector Mediated Gene Therapy for Ophthalmic Diseases
29 Apr 21
The present invention provides compositions and methods for treating an ocular condition and/or disease.
Rasappa Arumugham, Arun Upadhyay, Neena B. Haider
Filed: 26 Oct 20
Preservative free ocular compositions and methods for using the same for treating dry eye disease and other eye disorders
24 Aug 20
The present invention provides a preservative free ophthalmic formulation.
Sandeep Jain, Uday Bhaskar Kompella, Shankar Musunuri
Filed: 29 Jan 18
Ophthalmic compositions and methods of use
10 Feb 20
The present invention provides a composition comprising two or more of the following pharmaceutically active compounds: (i) an alpha 2 adrenergic agonist; (ii) a corticosteroid; (iii) a lymphocyte function-associated antigen antagonist; (iv) a non-steroidal anti-inflammatory drug (NSAID); (v) a sodium channel blocker; and (vi) an antibiotic, provided at least one of the pharmaceutically active compound is selected from the group consisting of (i) alpha 2 adrenergic agonist and (ii) corticosteroid.
Shankar Musunuri, Sandeep Jain, Rasappa Arumugham, Arun K. Upadhyay, Matthew Nudell, Gopalam Somasekhar
Filed: 4 Apr 18
Patents are sorted by USPTO publication date, most recent first